Therabel

Therabel is a privately-owned pharmaceutical company with a European heritage dating back to 1945. (therabel.com ) The company has achieved extensive international expansion through both acquisitions and organic growth. (therabel.com ) Therabel's product portfolio is primarily developed through collaborations with other pharmaceutical companies, ensuring that partnered products consistently receive the highest level of commitment and focus. (therabel.com ) Therabel's mission is to bring safe and effective therapeutic solutions developed by its partners to European healthcare professionals and patients through its expertise in market access and commercialization. (therabel.com ) The company's vision is to become one of the leading partnership-driven pharmaceutical companies in Europe by expanding and maximizing its partnered products portfolio and geographic footprint. (therabel.com ) The company's culture is characterized by a human-scale group of professionals bound by common goals and objectives. Since 1945, Therabel has grown by establishing long-term partnerships, building a team characterized by expertise, dedication, and a collaborative spirit. (therabel.com ) Therabel's corporate values include agility, collaboration, and responsibility. The company evolves with agility and integrity in a fast-changing European healthcare environment, fostering creativity and open-mindedness. (therabel.com ) Collaboration is key to Therabel's success, relying on constant learning through the exchange of knowledge, experience, and new ideas within the organization and with partners. (therabel.com ) Responsibility is demonstrated by building trust through commitment to results and adherence to the best industry standards, placing ethics at the core of its values. (therabel.com ) Therabel's current product portfolio consists mostly of specialty care and primary care pharmaceutical drugs, as well as over-the-counter (OTC) products. (therabel.com ) The company is pursuing strategic directions to develop its focus on OTC business and reinforce its specialty care portfolio with increased emphasis on niche and hospital care therapies, ranging from pharmaceutical and biological products to diagnostic solutions. (therabel.com ) Therabel's prescription key franchises include cardiology, pain, supportive care, respiratory, urology, and gastroenterology. (therabel.com ) In cardiology, the company provides therapeutic solutions addressing niche pathologies such as pulmonary arterial hypertension, as well as more widespread conditions like angina pectoris and heart failure prevention. (therabel.com ) The pain franchise covers the entire WHO pain ladder, with NSAIDs, tramadol products, and fentanyl products. (therabel.com ) The supportive care franchise focuses on managing secondary conditions arising from serious diseases such as cancer or HIV infection, including oral fungal infections and breakthrough cancer pain. (therabel.com ) The respiratory franchise addresses chronic obstructive pulmonary disease (COPD), allergic rhinitis, and cough and cold. (therabel.com ) In urology, Therabel targets conditions such as benign prostatic hyperplasia (BPH) and interstitial cystitis/painful bladder syndrome. (therabel.com ) The gastroenterology franchise addresses diarrhea, constipation, biliary dysfunction, and gastro-oesophageal reflux disease. (therabel.com ) Therabel's business development strategy focuses on growing its product portfolio through partnerships on new, close-to-market, or marketed products in major European countries. (therabel.com ) The company aims to establish long-term partnerships to maximize the potential of partnered products through ethical and creative promotional approaches. (therabel.com ) While the main therapeutic focus is currently on cardiology, pain, supportive care, respiratory, urology, and gastroenterology, Therabel follows an opportunistic approach and considers partnering on products to which it can bring substantial value, including pharmaceutical products (Rx and OTC), medical devices, diagnostic solutions, and food supplements. (therabel.com ) Therabel's products are marketed through commercialization partners in various countries, including Benin, Burkina Faso, Cambodia, Cameroon, Chad, Democratic Republic of the Congo, Gabon, Guinea, Ivory Coast, Lebanon, Mali, Mauritania, Niger, Republic of the Congo, Senegal, Switzerland, and Togo. (therabel.com ) Key facts and figures about Therabel include a group turnover of €59.1 million in 2019, commercial presence at hospital and retail levels collaborating with physicians and pharmacists, direct commercial presence in France, Belgium, and the Grand Duchy of Luxembourg, a strong privileged partners network covering other European countries, a business model focused on providing regulatory support, market access, and sales & marketing activities, and a portfolio fueled by partnerships and alliances, including in- and out-licensing, distribution, joint ventures, co-marketing, and co-promotion. (therabel.com ) Therabel's management team includes Philippe Burtonboy overseeing Finance and Administration, Brigitte Berton leading Regulatory Affairs, Pharmacovigilance, and Quality Assurance, Leo Drennan managing Supply Chain, and Laurent Kirsch responsible for France, Belgium, and Luxembourg. (therabel.com ) Therabel's history includes the acquisition of La Meuse in Belgium in 1986, Lucien Pharma in France in 1991, Gienne Pharma in Italy in 1997, and Javelin Pharmaceuticals UK Ltd. in the United Kingdom in 2009. (therabel.com ) The company also established Therabel Industries, a production site in the south of France, in 1992, and created affiliates in Ireland in 1999, the Netherlands in 2007, and Germany in 2010. (therabel.com ) Therabel's objective is to provide safe and effective therapeutic solutions developed by its partners, making these available to European healthcare professionals and patients through its expertise in market access and commercialization. (therabel.com ) The company believes that long-term success relies on a commitment to a clear set of values and strict compliance with industry regulations, ensuring the highest standard of quality and securing social and ethical responsibility. (therabel.com ) Therabel's corporate culture and human-scale business structure allow for personalized contact and dynamic implementation of innovative approaches. (therabel.com ) Therabel is not driven by short-term financial results but rather by medium to long-term objectives. (therabel.com ) Its mission is to continue building on the foundations laid over more than half a century and to become one of the leading partnership-driven pharmaceutical companies in Europe, while remaining dedicated to